ADC Therapeutics (NYSE:ADCT) Earnings Information
ADC Therapeutics last announced its quarterly earnings data on March 17th, 2021. The reported ($0.73) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.68) by $0.05. ADC Therapeutics has generated ($2.36) earnings per share over the last year. ADC Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 17th, 2021 based off prior year's report dates.
ADC Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
ADC Therapeutics (NYSE:ADCT) Earnings Estimates
Current Year EPS Consensus Estimate: $-3.83 EPS
Next Year EPS Consensus Estimate: $-2.79 EPS
ADC Therapeutics (NYSE ADCT) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)